Profusa (PFSA) Notes Payables (2023 - 2026)
Profusa posted quarterly Notes Payables of $710000.0 for Q1 2026, down 92.23% year-on-year from $9.1 million in Q1 2025, and down 24.95% on a QoQ basis from $946000.0 in Q4 2025.
Profusa (PFSA) has 4 years of Notes Payables data on file, last reported at $710000.0 in Q1 2026.
- For the quarter ending Q1 2026, Notes Payables fell 92.23% year-over-year to $710000.0; the trailing twelve-month figure through Mar 2026 stood at $710000.0 (down 92.23% YoY), and the FY2025 full-year result was $946000.0, up 3.96% from the prior year.
- Notes Payables for Q1 2026 stood at $710000.0, down from $946000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $9.1 million in Q1 2025 and bottomed at $310999.0 in Q2 2023.
- The 4-year median for Notes Payables is $995500.0 (2025), against an average of $1.8 million.
- The widest annual swing landed in 2025, when Notes Payables surged 623.59%; it then plunged 92.23% in 2026.
- A 4-year view of Notes Payables shows it stood at $944118.0 in 2023, then slipped by 3.61% to $910000.0 in 2024, then grew by 3.96% to $946000.0 in 2025, then fell by 24.95% to $710000.0 in 2026.
- The last three Notes Payables figures came in at $710000.0 (Q1 2026), $946000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Profusa | 574,294.01 | 574,294.01 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 710,000.00 |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.92 Mn |
| Mar 31, 2025 | 23,487.00 |
| Dec 31, 2024 | 910,000.00 |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 944,118.00 |
| Sep 30, 2023 | 601,239.00 |
| Jun 30, 2023 | 310,999.00 |